Mobile

A Randomized Open-Label Study of Darbepoetin alfa Administered Every Three Weeks with or without Parenteral Iron in Anemic Subjects with Nonmyeloid Malignancies Receiving Chemotherapy

Update Il y a 5 ans
Reference: EUCTR2004-001417-33

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To compare hematopoietic response after 16 weeks of treatment with 500 mcg once every 3 weeks (Q3W) darbepoetin alfa and either IV iron or following standard practice (oral iron or no iron supplementation).

Inclusion criteria

  • Chemotherapy-induced Anemia

Links